Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer

BACKGROUND: The 21-gene Recurrence Score assay (RS) is prognostic for women with node-negative, estrogen receptor (ER)-positive breast cancer (BC) treated with tamoxifen. A low RS predicts little benefit of chemotherapy. For node-positive BC, we investigated whether RS was prognostic in women treate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Albain, Kathy S., Barlow, William E., Shak, Steven, Hortobagyi, Gabriel N., Livingston, Robert B., Yeh, I-Tien, Ravdin, Peter, Bugarini, Roberto, Baehner, Frederick L., Davidson, Nancy E., Sledge, George W., Winer, Eric P., Hudis, Clifford, Ingle, James N., Perez, Edith A., Pritchard, Kathleen I., Shepherd, Lois, Gralow, Julie R., Yoshizawa, Carl, Allred, D. Craig, Osborne, C. Kent, Hayes, Daniel F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058239/
https://ncbi.nlm.nih.gov/pubmed/20005174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(09)70314-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi